Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 15h ago.
| Ticker | Firm | Action | Rating | Target | Date |
|---|---|---|---|---|---|
| ASNDAscendis Pharma A/S | HC Wainwright & Co. | Initiated | Buy | $345 | Aug 27 |
| COAGHemab Therapeutics Holdings, Inc. | HC Wainwright & Co. | Initiated | Buy | $40 | Jun 17 |
Showing the 2 most recent actions over 90 days.